We have started a series of articles that will be published on medium.com. The first article provides a brief history of the Methuselah Foundation and highlights Oisín Biotechnologies – a company we provided founding capital for and continued incubation services and support. With “bio-techie” Matthew Scholz as CEO, Oisín Biotechnologies is tackling aging by selectively killing senescent cells with a targeted DNA approach.